US3729568A - Acne treatment - Google Patents
Acne treatment Download PDFInfo
- Publication number
- US3729568A US3729568A US00860296A US3729568DA US3729568A US 3729568 A US3729568 A US 3729568A US 00860296 A US00860296 A US 00860296A US 3729568D A US3729568D A US 3729568DA US 3729568 A US3729568 A US 3729568A
- Authority
- US
- United States
- Prior art keywords
- vitamin
- acid
- acne
- glycol
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/26—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing rings other than six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- Acne is a dermatological disorder which is more prevalent in adolescence and is found mainly within the age group of about to 22. As it occurs primarily in the face and trunk are'as, affecting the appearance of the patient, it probably causes more mental pain and anguish to those afiiicted than many other diseases which, from a physical standpoint, may be much more severe.
- the basic lesion of acne is the comedo or blackhead of a pilosebaceous follicle. The condition may be mild and transient with only a few blackheads which can readily be ejected by pressure and are of little concern, or may be severe, persistent, and very disfiguring with the more serious cases frequently leaving permanent scarring.
- Vitamin A Its Effects on Acne, Northwest Med., 42; 219-225, August 1943
- other investigators 3,729,568 Patented Apr. 24, 1973 have felt it to be ineffective
- Easterson, J. A. D. et al. Vitamin A in Acne Vulgaris, Brit. Med. J., 2: 294-296, August 1963
- Lynch, F. W. et al. Acne Vulgaris Treated With Vitamin A, Arch Derm., 55: 355, 357, March 1947, and Mitchell, G. H. et al., Results of Treatment of Acne Vulgaris by Intramuscular Injections of Vitamin A, Arch. Derm., 64: 428430, October 1951).
- Vitamin A acid has been applied topically, Beer (Beer, Von P., Informen iiber diecode der Vitamin A-Sure, Dermatologica, 124: 192-l95, March 1962) and Stiittgen (Stiittgen, G., Zur Lokal opposition von Keratosen mit Vitamin A-Saure, Dermatologica, 124: 6580, February 1962) achieving good results in those hyperkeratotic disorders which are responsive to high oral doses of vitamin A. Among those treated by Beer and Stiittgen were patients with acne; however, these investigators reported no eifective results on this disorder. British Patent 906,000 discloses a cosmetic preparation containing vitamin A acid for regulation of the cornification processes of human skin.
- Vitamin A acid is used in the present specification and claims refers to a composition in which the terminal methylene group of vitamin A has been replaced by a carboxyl group. It is also known as retinoic acid.
- the vitamin A acid is preferably applied in a liquid solvent.
- a composition found to be particularly effective is vitamin A acid dispersed in small amounts in a watermiscible (substantially oiland fat-free) liquid carrier made up of hydrophylic liquids having a high solvating action.
- a particularly suitable solvent carrier in this regard consists essentially of a combination of (A) from about 25 to about by weight, of ethyl alcohol or isopropyl alcohol, preferably the former, and (B) the balance essentially a liquid glycol above ethylene glycol or a liquid glycol above ethylene glycol and a liquid ethylene glycol mono methyl or mono ethyl ether.
- the balance is essentially a combination of a liquid glycol and a liquid ethylene glycol mono ether
- the former will usually predominate; that is to say, the liquid glycol will be present in an amount, by weight, greater than the liquid ethylene glycol mono ether.
- suitable glycols are liquid polyethylene glycols, such as polyethylene glycol 400, propylene glycol and liquid polypropylene glycols. Of these the polyethylene glycols and propylene glycol are preferred.
- suitable liquid ethylene glycol ethers are the mono-, diand triethylene glycol monomethyl ethers and the mono-, diand triethylene glycol monoethyl ethers. Of these the monoand diethylene glycol monoethers are preferred.
- Small amounts of other materials which do not materially alter the advantageous characteristics of the composition may be included. For example, a small amount of polyethylene glycol 4000 may be included to thicken the composition. Likewise, a small amount of an antioxidant, like butylated hydroxytoluene, may be included as a stabilizer to increase shelf life.
- Typical such solvent carriers are as follows (percent being by weight):
- the concentration of the vitamin A acid in the topically-applied composition is generally in the order of about 0.1%, by weight, of the applied composition.
- the vitamin A acid concentration in the applied composition may range from 0.20% to 0.5%, by weight, with a concentration in the range of from about 0.05 to about 0.25% being preferred.
- the vitamin A acid composition is applied daily until the desired relief is obtained, and this may require one or two (or possibly three) applications each day, depending upon the particular individual. Normally the treatment requires at least a month. Thus, acne in its mildest form (only a small number of comed'ones) may be substantially cleared in four to six weeks. However, more severe cases may require two to three months or longer.
- the vitamin A acid appears to have an effect substantially diiferent from the irritants generally employed. Its effect is twofold: it causes an intercellular edema of the epithelium lining the comedo which thereby becomes porous allowing products within the comedo to leak into the tissue. This incites the inflammation which converts the comedones. Secondly, it increases the rate of reproduction of epithelial cells so that the horny cells stream out more rapidly carrying the impaction with them. This is illustrated, for example, in the drawings wherein the several tfigures show the progressive stages of expulsion of the comedo, inflammatory in one case, increased keratinization in other. Not infrequently, new pustules and papules suddenly appear during the initial period of therapy.
- FIG. 1 shows an open comedo (blackhead) before treatment.
- FIG. 2 Shows the inflammatory reaction, caused by the present treatment, destroying epith'elia lining with consequent unseating of the comedo which will soon be exfoliated.
- FIG. 3 shows extrusion of the comedo as a result of speeding up of keratinization. Horny cells are being produced at an accelerated rate, and the comedo is being swept out by this stream of cells.
- FIG. 4 shows normal sebaceous follicles of the face. These follicles are the sites in which cornedones form.
- FIG. 5 shows the filling of the follicle with horny material, the intermediate stage of comedo formation.
- the method of treating acne comprising applying vitamin A acid topically to the aflected area in a concentration eflective for the treatment of acne and repeating such applications daily, whereby said applications result in the peeling and diffuse redness of the skin treated, and continuing said treatment until the acne has subsided.
- said carrier consists essentially of (A) from about 25 to 75%, by weight, of an alcohol selected from the group consisting of ethyl and isopropyl, alcohol and 5 (B) the balance being essentially a liquid selected from the group consisting of (a) a liquid glycol above ethylene glycol, and (b) a mixture of a liquid glycol above ethylene glycol and a liquid lower alkyl ether of an ethylene glycol selected from the group consisting of the monomethyl and monoethyl ethers.
- said alcohol is ethyl alcohol
- said liquid glycol is a liquid polyethylene 10 glycol
- said liquid ethylene glycol mono ether is selected from the group consisting of monoethylene glycol monomethyl ether, monoethylene glycol monoethyl ether, diethyleneglycol monomethyl ether and diethyleneglycol monoethyl ether.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86029669A | 1969-09-23 | 1969-09-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3729568A true US3729568A (en) | 1973-04-24 |
Family
ID=25332903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US00860296A Expired - Lifetime US3729568A (en) | 1969-09-23 | 1969-09-23 | Acne treatment |
Country Status (7)
Country | Link |
---|---|
US (1) | US3729568A (de) |
CA (1) | CA945069A (de) |
DE (1) | DE2046119C2 (de) |
FR (1) | FR2070083B1 (de) |
GB (1) | GB1325732A (de) |
IT (1) | IT1059655B (de) |
ZA (1) | ZA706459B (de) |
Cited By (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3882244A (en) * | 1971-12-13 | 1975-05-06 | Univ California | Method of treating acne with a c{hd 20 {b acid |
US3906108A (en) * | 1973-10-12 | 1975-09-16 | Johnson & Johnson | Stabilized tretinoin cream emulsion |
US3932665A (en) * | 1974-04-05 | 1976-01-13 | Scott Eugene J Van | Process for the treatment of acne vulgaris utilizing retinal |
US3934028A (en) * | 1974-04-22 | 1976-01-20 | The Regents Of The University Of California | Acne and psoriasis treatment with retinoic acid analogs |
DE2601489A1 (de) * | 1975-01-17 | 1976-07-22 | Johnson & Johnson | Tretinoin enthaltende gelpraeparate |
US4021573A (en) * | 1974-04-22 | 1977-05-03 | The Regents Of The University Of California | Psoriasis treatment with retinoic acid analogs |
US4034114A (en) * | 1976-09-15 | 1977-07-05 | Yu Ruey J | Treatment of skin keratoses with retinal |
US4055659A (en) * | 1975-11-03 | 1977-10-25 | Johnson & Johnson | Retinoic acid derivatives |
US4108880A (en) * | 1975-11-03 | 1978-08-22 | Johnson & Johnson | Esters of retinoic acid |
US4126697A (en) * | 1975-11-03 | 1978-11-21 | Johnson & Johnson | Retinoic acid derivatives in the treatment of acne |
US4170229A (en) * | 1978-01-16 | 1979-10-09 | Dominion Pharmacal, Inc. | Method for improved health care of hair and scalp using a vitamin A aqueous emulsion |
US4190594A (en) * | 1975-11-03 | 1980-02-26 | Johnson & Johnson | Retinoic acid derivatives |
US4200647A (en) * | 1977-12-21 | 1980-04-29 | Hoffmann-La Roche Inc. | Vitamin A compositions to treat rheumatic disease |
US4214000A (en) * | 1978-10-30 | 1980-07-22 | Johnson & Johnson | Zinc salt of all-trans-retinoic acid for the treatment of acne |
US4239781A (en) * | 1979-05-03 | 1980-12-16 | Roy Edwards | Method for treating skin ailments |
US4247547A (en) * | 1979-03-19 | 1981-01-27 | Johnson & Johnson | Tretinoin in a gel vehicle for acne treatment |
US4603146A (en) * | 1984-05-16 | 1986-07-29 | Kligman Albert M | Methods for retarding the effects of aging of the skin |
US4843096A (en) * | 1985-06-26 | 1989-06-27 | Stiefel Laboratories, Inc. | Treatment of acne |
US4877805A (en) * | 1985-07-26 | 1989-10-31 | Kligman Albert M | Methods for treatment of sundamaged human skin with retinoids |
US4889847A (en) * | 1986-11-03 | 1989-12-26 | Ortho Pharmaceutical Corporation | Prevention of glucocorticoid-induced skin atrophy |
WO1990014833A1 (en) * | 1989-06-07 | 1990-12-13 | Bazzano Gail S | Slow release vehicles for minimizing skin irritancy of topical compositions |
US4985235A (en) * | 1988-08-02 | 1991-01-15 | Kligman Albert M | Treatment of periodontoclasia with retinoic acid |
US5019569A (en) * | 1986-11-03 | 1991-05-28 | Ortho Pharmaceutical Corporation | Reversal of glucocorticoid-induced skin atrophy |
AU614643B2 (en) * | 1988-08-02 | 1991-09-05 | Albert M. Kligman | Treatment of periodontoclasia with retinoic acid |
US5051449A (en) * | 1991-02-27 | 1991-09-24 | Kligman Albert M | Treatment of cellulite with retinoids |
US5124313A (en) * | 1989-06-02 | 1992-06-23 | Schaeffer Hans A | Methods of improved skin care and the treatment of dermatological conditions |
US5183817A (en) * | 1981-02-17 | 1993-02-02 | Bazzano Gail S | Combinations of retinoids and minoxidil-type compounds for hair growth |
WO1993006086A1 (en) * | 1991-09-24 | 1993-04-01 | Pfizer Inc. | Retinoids and their use in treating skin diseases and leukemia |
US5273739A (en) * | 1990-12-07 | 1993-12-28 | Jim Baral | Composition and treatment for darkening hair color |
US5380764A (en) * | 1989-06-08 | 1995-01-10 | Herzog; Paul | Composition of vitamin A, glucose and hydrogen peroxide for cosmetic or pharmaceutical use |
US5459153A (en) * | 1990-03-27 | 1995-10-17 | Leung; Lit-Hung | Composition and methods for treatment of acne vulgaris and for retardation of aging |
EP0699439A2 (de) | 1994-08-31 | 1996-03-06 | Pfizer Inc. | Behandlung von durch Talgdrüse verursachten Erkrankungen mit Inhibitoren der Acyl CoA Cholesterin Acyltransferase |
US5514672A (en) * | 1981-02-17 | 1996-05-07 | Bazzano; Gail S. | Use of retinoids and compositions containing same for hair growth |
US5643584A (en) * | 1992-04-16 | 1997-07-01 | Ortho Pharmaceutical Corporation | Aqueous gel retinoid dosage form |
US5661141A (en) * | 1995-03-27 | 1997-08-26 | Petrow; Vladimir | 19-oxygenated steroids as therapeutic agents |
US5670547A (en) * | 1989-04-17 | 1997-09-23 | Dow Pharmaceutical Sciences | Moisturizing vehicle for topical application of vitamin A acid |
US5698593A (en) * | 1988-04-26 | 1997-12-16 | The United States Of America As Represented By The Department Of Health And Human Services | Method for treating acne |
WO1998050023A1 (en) * | 1997-05-09 | 1998-11-12 | Kligman Douglas E | Use of high dose retinoids for the treatment of skin disorders |
USRE36068E (en) * | 1981-08-28 | 1999-01-26 | Kligman; Albert M. | Methods for treatment of sundamaged human skin with retinoids |
US5998395A (en) * | 1992-02-07 | 1999-12-07 | Kligman; Albert M. | Methods of treating inflammatory dermatosis |
US6028105A (en) * | 1989-04-06 | 2000-02-22 | Nigra; Thomas P. | Topical drug delivery composition and method |
US6063817A (en) * | 1997-02-21 | 2000-05-16 | Bristol-Myers Squibb Company | Use of substituted (5,6) dihydronaphthalenyl compounds having retinoid-like activity to prevent or reduce ischemic injury |
WO2000033877A1 (en) * | 1998-12-04 | 2000-06-15 | Johnson And Johnson Consumer Companies, Inc. | Anhydrous topical skin preparations |
US6169110B1 (en) | 1995-11-21 | 2001-01-02 | Vivant Pharmaceuticals | Rejuvenating the skin using a combination of vitamin A and alphahydroxy acids |
US6248763B1 (en) | 1998-05-19 | 2001-06-19 | Scivoletto Rosemarie | Composition for treating skin conditions |
EP1159956A2 (de) * | 2000-05-01 | 2001-12-05 | Johnson & Johnson Consumer Companies, Inc. | Wasserfreie topische Zubereitungen für die Haut |
US6344448B1 (en) | 1992-09-11 | 2002-02-05 | Stb Family Limited Partnership | Composition for the treatment of hair loss |
US6429218B1 (en) | 1997-05-19 | 2002-08-06 | Joseph Scivoletto | Method of controlling niacin concentration in lotion |
US20040157936A1 (en) * | 1998-12-04 | 2004-08-12 | Johnson And Johnson Consumer Companies Inc. | Anhydrous topical skin preparations |
US20050159485A1 (en) * | 2002-01-04 | 2005-07-21 | Jost-Price Edward R. | Combinations for the treatment of immunoinflammatory disorders and proliferative skin diseases |
US20050255130A1 (en) * | 2004-05-11 | 2005-11-17 | Mohan Vishnupad | Retinoid solutions and formulations made therefrom |
US20060014834A1 (en) * | 2004-05-11 | 2006-01-19 | Mohan Vishnupad | Retinoid solutions and formulations made therefrom |
US20060100181A1 (en) * | 2002-05-03 | 2006-05-11 | Jost-Price Edward R | Combinations for the treatment of inflammatory skin disorders |
US20060122282A1 (en) * | 2004-12-03 | 2006-06-08 | Todd Leonard | Method for treating skin disorders with xanthophylls |
US20060172955A1 (en) * | 2000-12-12 | 2006-08-03 | Mohan Vishnupad | Antibiotic/benzoyl peroxide dispenser |
US20060189552A1 (en) * | 2000-12-12 | 2006-08-24 | Mohan Vishnupad | Dispenser for dispensing three or more actives |
EP1714640A1 (de) * | 1992-07-13 | 2006-10-25 | Shiseido Company, Ltd. | Retinolenthaltige stabilisierte Hautpflegemittel zur äusserlichen Anwendung |
US20070141015A1 (en) * | 2005-12-16 | 2007-06-21 | Shane Malek | Topical administration carrier composition and therapeutic formulations comprising same |
US20080139518A1 (en) * | 2006-12-04 | 2008-06-12 | Concert, Llc | Topical compositions for treatment of skin conditions |
US20090264527A1 (en) * | 2008-04-14 | 2009-10-22 | Skinvisible Pharmaceuticals, Inc. | Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition |
CN104382798A (zh) * | 2014-11-28 | 2015-03-04 | 李正梅 | 一种面膜及其制备方法 |
US20150094351A1 (en) * | 2008-01-23 | 2015-04-02 | Thesan Pharmaceuticals, Inc. | Composition for topical use |
US9962444B2 (en) | 2016-09-27 | 2018-05-08 | Shane Malek | Pharmacokinetically extended action topical hair growth formulation, and administration method |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7612936L (sv) * | 1976-11-19 | 1978-05-20 | Pharmacia Ab | Hygienisk-kosmetiska kompositioner |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL257621A (de) * | 1959-11-23 | |||
GB901659A (en) * | 1959-11-25 | 1962-07-25 | Carolina Julia Cornelia Vintge | Ointment for the treatment of acne vulgaris |
CA945068A (en) * | 1967-10-25 | 1974-04-09 | Albert M. Kligman | Composition and method of treating acne |
-
1969
- 1969-09-23 US US00860296A patent/US3729568A/en not_active Expired - Lifetime
-
1970
- 1970-09-18 DE DE2046119A patent/DE2046119C2/de not_active Expired
- 1970-09-22 IT IT53580/70A patent/IT1059655B/it active
- 1970-09-22 ZA ZA706459A patent/ZA706459B/xx unknown
- 1970-09-22 CA CA093,796A patent/CA945069A/en not_active Expired
- 1970-09-23 FR FR7034457A patent/FR2070083B1/fr not_active Expired
- 1970-09-23 GB GB4527070A patent/GB1325732A/en not_active Expired
Cited By (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3882244A (en) * | 1971-12-13 | 1975-05-06 | Univ California | Method of treating acne with a c{hd 20 {b acid |
US3906108A (en) * | 1973-10-12 | 1975-09-16 | Johnson & Johnson | Stabilized tretinoin cream emulsion |
US3932665A (en) * | 1974-04-05 | 1976-01-13 | Scott Eugene J Van | Process for the treatment of acne vulgaris utilizing retinal |
US3934028A (en) * | 1974-04-22 | 1976-01-20 | The Regents Of The University Of California | Acne and psoriasis treatment with retinoic acid analogs |
US4021573A (en) * | 1974-04-22 | 1977-05-03 | The Regents Of The University Of California | Psoriasis treatment with retinoic acid analogs |
DE2601489A1 (de) * | 1975-01-17 | 1976-07-22 | Johnson & Johnson | Tretinoin enthaltende gelpraeparate |
US4108880A (en) * | 1975-11-03 | 1978-08-22 | Johnson & Johnson | Esters of retinoic acid |
US4055659A (en) * | 1975-11-03 | 1977-10-25 | Johnson & Johnson | Retinoic acid derivatives |
US4126697A (en) * | 1975-11-03 | 1978-11-21 | Johnson & Johnson | Retinoic acid derivatives in the treatment of acne |
US4190594A (en) * | 1975-11-03 | 1980-02-26 | Johnson & Johnson | Retinoic acid derivatives |
US4034114A (en) * | 1976-09-15 | 1977-07-05 | Yu Ruey J | Treatment of skin keratoses with retinal |
US4200647A (en) * | 1977-12-21 | 1980-04-29 | Hoffmann-La Roche Inc. | Vitamin A compositions to treat rheumatic disease |
US4170229A (en) * | 1978-01-16 | 1979-10-09 | Dominion Pharmacal, Inc. | Method for improved health care of hair and scalp using a vitamin A aqueous emulsion |
US4214000A (en) * | 1978-10-30 | 1980-07-22 | Johnson & Johnson | Zinc salt of all-trans-retinoic acid for the treatment of acne |
US4247547A (en) * | 1979-03-19 | 1981-01-27 | Johnson & Johnson | Tretinoin in a gel vehicle for acne treatment |
US4239781A (en) * | 1979-05-03 | 1980-12-16 | Roy Edwards | Method for treating skin ailments |
US5514672A (en) * | 1981-02-17 | 1996-05-07 | Bazzano; Gail S. | Use of retinoids and compositions containing same for hair growth |
US5183817A (en) * | 1981-02-17 | 1993-02-02 | Bazzano Gail S | Combinations of retinoids and minoxidil-type compounds for hair growth |
USRE36068E (en) * | 1981-08-28 | 1999-01-26 | Kligman; Albert M. | Methods for treatment of sundamaged human skin with retinoids |
US4603146A (en) * | 1984-05-16 | 1986-07-29 | Kligman Albert M | Methods for retarding the effects of aging of the skin |
US4843096A (en) * | 1985-06-26 | 1989-06-27 | Stiefel Laboratories, Inc. | Treatment of acne |
US4877805A (en) * | 1985-07-26 | 1989-10-31 | Kligman Albert M | Methods for treatment of sundamaged human skin with retinoids |
US4889847A (en) * | 1986-11-03 | 1989-12-26 | Ortho Pharmaceutical Corporation | Prevention of glucocorticoid-induced skin atrophy |
US5019569A (en) * | 1986-11-03 | 1991-05-28 | Ortho Pharmaceutical Corporation | Reversal of glucocorticoid-induced skin atrophy |
US5698593A (en) * | 1988-04-26 | 1997-12-16 | The United States Of America As Represented By The Department Of Health And Human Services | Method for treating acne |
US4985235A (en) * | 1988-08-02 | 1991-01-15 | Kligman Albert M | Treatment of periodontoclasia with retinoic acid |
AU614643B2 (en) * | 1988-08-02 | 1991-09-05 | Albert M. Kligman | Treatment of periodontoclasia with retinoic acid |
US6586473B1 (en) * | 1989-04-06 | 2003-07-01 | Medicis Pharmaceutical Corporation | Topical drug delivery composition and method |
US6028105A (en) * | 1989-04-06 | 2000-02-22 | Nigra; Thomas P. | Topical drug delivery composition and method |
US5670547A (en) * | 1989-04-17 | 1997-09-23 | Dow Pharmaceutical Sciences | Moisturizing vehicle for topical application of vitamin A acid |
US5124313A (en) * | 1989-06-02 | 1992-06-23 | Schaeffer Hans A | Methods of improved skin care and the treatment of dermatological conditions |
USRE41134E1 (en) | 1989-06-07 | 2010-02-16 | Alyzan, Inc. | Slow release vehicles for minimizing skin irritancy of topical compositions |
US5721275A (en) * | 1989-06-07 | 1998-02-24 | Bazzano; Gail S. | Slow release vehicles for minimizing skin irritancy of topical compositions |
WO1990014833A1 (en) * | 1989-06-07 | 1990-12-13 | Bazzano Gail S | Slow release vehicles for minimizing skin irritancy of topical compositions |
US5380764A (en) * | 1989-06-08 | 1995-01-10 | Herzog; Paul | Composition of vitamin A, glucose and hydrogen peroxide for cosmetic or pharmaceutical use |
US5459153A (en) * | 1990-03-27 | 1995-10-17 | Leung; Lit-Hung | Composition and methods for treatment of acne vulgaris and for retardation of aging |
US5273739A (en) * | 1990-12-07 | 1993-12-28 | Jim Baral | Composition and treatment for darkening hair color |
WO1992015293A1 (en) | 1991-02-27 | 1992-09-17 | Kligman Albert M | Treatment of cellulite with retinoids |
US5051449A (en) * | 1991-02-27 | 1991-09-24 | Kligman Albert M | Treatment of cellulite with retinoids |
WO1993006086A1 (en) * | 1991-09-24 | 1993-04-01 | Pfizer Inc. | Retinoids and their use in treating skin diseases and leukemia |
US5998395A (en) * | 1992-02-07 | 1999-12-07 | Kligman; Albert M. | Methods of treating inflammatory dermatosis |
US5643584A (en) * | 1992-04-16 | 1997-07-01 | Ortho Pharmaceutical Corporation | Aqueous gel retinoid dosage form |
EP1714640A1 (de) * | 1992-07-13 | 2006-10-25 | Shiseido Company, Ltd. | Retinolenthaltige stabilisierte Hautpflegemittel zur äusserlichen Anwendung |
US6344448B1 (en) | 1992-09-11 | 2002-02-05 | Stb Family Limited Partnership | Composition for the treatment of hair loss |
EP0699439A2 (de) | 1994-08-31 | 1996-03-06 | Pfizer Inc. | Behandlung von durch Talgdrüse verursachten Erkrankungen mit Inhibitoren der Acyl CoA Cholesterin Acyltransferase |
US5661141A (en) * | 1995-03-27 | 1997-08-26 | Petrow; Vladimir | 19-oxygenated steroids as therapeutic agents |
US6169110B1 (en) | 1995-11-21 | 2001-01-02 | Vivant Pharmaceuticals | Rejuvenating the skin using a combination of vitamin A and alphahydroxy acids |
US6063817A (en) * | 1997-02-21 | 2000-05-16 | Bristol-Myers Squibb Company | Use of substituted (5,6) dihydronaphthalenyl compounds having retinoid-like activity to prevent or reduce ischemic injury |
WO1998050023A1 (en) * | 1997-05-09 | 1998-11-12 | Kligman Douglas E | Use of high dose retinoids for the treatment of skin disorders |
US6008254A (en) * | 1997-05-09 | 1999-12-28 | Kligman; Douglas E. | Method of treating skin disorders with high-strength tretinoin |
US6228887B1 (en) | 1997-05-09 | 2001-05-08 | Douglas E. Kligman | Method of treating skin disorders with high-strength retinoids |
US6429218B1 (en) | 1997-05-19 | 2002-08-06 | Joseph Scivoletto | Method of controlling niacin concentration in lotion |
US6248763B1 (en) | 1998-05-19 | 2001-06-19 | Scivoletto Rosemarie | Composition for treating skin conditions |
US7179475B1 (en) | 1998-12-04 | 2007-02-20 | Johnson & Johnson Consumer Companies, Inc. | Anhydrous topical skin preparations |
US6238683B1 (en) | 1998-12-04 | 2001-05-29 | Johnson & Johnson Consumer Companies, Inc. | Anhydrous topical skin preparations |
US20040157936A1 (en) * | 1998-12-04 | 2004-08-12 | Johnson And Johnson Consumer Companies Inc. | Anhydrous topical skin preparations |
AU778524B2 (en) * | 1998-12-04 | 2004-12-09 | Johnson & Johnson Consumer Companies, Inc. | Anhydrous topical skin preparations |
WO2000033877A1 (en) * | 1998-12-04 | 2000-06-15 | Johnson And Johnson Consumer Companies, Inc. | Anhydrous topical skin preparations |
US8232276B2 (en) | 1998-12-04 | 2012-07-31 | Johnson & Johnson Comsumer Companies, Inc. | Anhydrous topical skin preparations |
EP1645287A3 (de) * | 1998-12-04 | 2006-06-07 | Johnson and Johnson Consumer Companies, Inc. | Wasserfreie topische Zubereitungen zur Applikation auf die Haut |
EP1645287A2 (de) * | 1998-12-04 | 2006-04-12 | Johnson and Johnson Consumer Companies, Inc. | Wasserfreie topische Zubereitungen zur Applikation auf die Haut |
EP1159956A3 (de) * | 2000-05-01 | 2003-01-29 | Johnson & Johnson Consumer Companies, Inc. | Wasserfreie topische Zubereitungen für die Haut |
EP1159956A2 (de) * | 2000-05-01 | 2001-12-05 | Johnson & Johnson Consumer Companies, Inc. | Wasserfreie topische Zubereitungen für die Haut |
US20060172955A1 (en) * | 2000-12-12 | 2006-08-03 | Mohan Vishnupad | Antibiotic/benzoyl peroxide dispenser |
US20060173076A1 (en) * | 2000-12-12 | 2006-08-03 | Mohan Vishnupad | Antibiotic/benzoyl peroxide dispenser |
US20060189552A1 (en) * | 2000-12-12 | 2006-08-24 | Mohan Vishnupad | Dispenser for dispensing three or more actives |
US20050159485A1 (en) * | 2002-01-04 | 2005-07-21 | Jost-Price Edward R. | Combinations for the treatment of immunoinflammatory disorders and proliferative skin diseases |
US20060100181A1 (en) * | 2002-05-03 | 2006-05-11 | Jost-Price Edward R | Combinations for the treatment of inflammatory skin disorders |
US20060280715A1 (en) * | 2004-05-11 | 2006-12-14 | Mohan Vishnupad | Retinoid solutions and formulations made therefrom |
US20050255130A1 (en) * | 2004-05-11 | 2005-11-17 | Mohan Vishnupad | Retinoid solutions and formulations made therefrom |
US20060014834A1 (en) * | 2004-05-11 | 2006-01-19 | Mohan Vishnupad | Retinoid solutions and formulations made therefrom |
US7662855B2 (en) | 2004-05-11 | 2010-02-16 | Imaginative Research Associates, Inc. | Retinoid solutions and formulations made therefrom |
US20060122282A1 (en) * | 2004-12-03 | 2006-06-08 | Todd Leonard | Method for treating skin disorders with xanthophylls |
US8119111B2 (en) | 2005-12-16 | 2012-02-21 | Celmatrix Corporation | Topical administration carrier composition and therapeutic formulations comprising same |
US20070141004A1 (en) * | 2005-12-16 | 2007-06-21 | Shane Malek | Topical administration carrier composition and therapeutic formulations comprising same |
US7749489B2 (en) | 2005-12-16 | 2010-07-06 | Celmatrix Corporation | Topical administration carrier composition and therapeutic formulations comprising same |
US20100298365A1 (en) * | 2005-12-16 | 2010-11-25 | Shane Malek | Topical administration carrier composition and therapeutic formulations comprising same |
US8147815B2 (en) | 2005-12-16 | 2012-04-03 | Celmatrix Corporation | Topical administration carrier composition and therapeutic formulations comprising same |
US20070141015A1 (en) * | 2005-12-16 | 2007-06-21 | Shane Malek | Topical administration carrier composition and therapeutic formulations comprising same |
US8444960B2 (en) | 2005-12-16 | 2013-05-21 | Celmatrix Corporation | Topical administration carrier composition and therapeutic formulations comprising same |
US20080139518A1 (en) * | 2006-12-04 | 2008-06-12 | Concert, Llc | Topical compositions for treatment of skin conditions |
US20150094351A1 (en) * | 2008-01-23 | 2015-04-02 | Thesan Pharmaceuticals, Inc. | Composition for topical use |
US9463182B2 (en) * | 2008-01-23 | 2016-10-11 | Thesan Pharmaceuticals, Inc. | Composition for topical use |
US20090264527A1 (en) * | 2008-04-14 | 2009-10-22 | Skinvisible Pharmaceuticals, Inc. | Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition |
US8299122B2 (en) | 2008-04-14 | 2012-10-30 | Skinvisible Pharmaceuticals, Inc. | Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition |
CN104382798A (zh) * | 2014-11-28 | 2015-03-04 | 李正梅 | 一种面膜及其制备方法 |
US9962444B2 (en) | 2016-09-27 | 2018-05-08 | Shane Malek | Pharmacokinetically extended action topical hair growth formulation, and administration method |
US10342872B2 (en) | 2016-09-27 | 2019-07-09 | Celmatrix Corporation | Pharmacokinetically extended action topical hair growth formulation, and administration method |
Also Published As
Publication number | Publication date |
---|---|
CA945069A (en) | 1974-04-09 |
ZA706459B (en) | 1972-04-26 |
FR2070083B1 (de) | 1974-05-24 |
DE2046119C2 (de) | 1984-05-30 |
IT1059655B (it) | 1982-06-21 |
GB1325732A (en) | 1973-08-08 |
DE2046119A1 (de) | 1971-04-22 |
FR2070083A1 (de) | 1971-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3729568A (en) | Acne treatment | |
US3906108A (en) | Stabilized tretinoin cream emulsion | |
US4247547A (en) | Tretinoin in a gel vehicle for acne treatment | |
US4542129A (en) | DHEA Formulations and methods for treating dry skin | |
EP0481007B1 (de) | VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL | |
US4607101A (en) | Method of treating acne vulgaris with a composition containing carbamide peroxide | |
KR100264829B1 (ko) | 좌창 또는 위스염모낭 염의 치료 | |
US20070122435A1 (en) | Topical dapsone for the treatment of acne | |
EP0215108B1 (de) | Mittel zur behandlung von akne vulgaris und deren herstellung | |
EP0336902A2 (de) | Feuchtigkeitszusammensetzung gegen Hautentzündungen und Verfahren zu ihrer Herstellung | |
US4352794A (en) | Beta-cyclodextrin as anti-acne agent | |
Lowe et al. | Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin | |
EP0281812A1 (de) | Zusammensetzung zur Behandlung von Akne | |
US6120756A (en) | Topical anionic salicylate for disorders of the skin | |
US3934028A (en) | Acne and psoriasis treatment with retinoic acid analogs | |
US4361584A (en) | Composition and method for the treatment of acne | |
US4021573A (en) | Psoriasis treatment with retinoic acid analogs | |
US5443844A (en) | Linoleic acid preparations for topical treatment of acne vulgaris | |
US4487782A (en) | Topical treatment of non-inflammatory acne | |
Handojo | The combined use of topical benzoyl peroxide and tretinoin in the treatment of acne vulgaris | |
US4035510A (en) | Treatment of acne utilizing N-methyldiethanolamine | |
US5240945A (en) | Method and compositions for treating acne | |
EP0086228B1 (de) | Verwendung von carbamidperoxid zur herstellung eines arzneimittels zur behandlung von akne vulgaris | |
JPH0130806B2 (de) |